IDEAYA Biosciences Company
IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
Investors
Funding Status:
IPO
Industry:
End-to-End Drug Development
Estimated Revenue:
$10M to $50M
Technology:
Biotechnology, Health Care, Therapeutics
Headquarters:
South San Francisco, California, United States
Total Funding:
306100000.0
Last Funding Date:
2022-09-14
Last Funding Type:
Post-IPO Equity
Employee Number:
101-250
Investors Number:
16.0
Founded Date:
2015-01-01